Ami Jo
Impact in
- Biotechnology top 5%
- Cancer Research and Treatments
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery
Papers in
-
- Nanoparticle-Based Drug Delivery 4
-
- Graphene and Nanomaterials Applications 2
- Co-authors
- Richey M. Davis (7 shared papers)Irving C. Allen (4 shared papers)Veronica M. Ringel‐Scaia (3 shared papers)Sheryl Coutermarsh‐Ott (2 shared papers)Bahareh Behkam (1 shared paper)Mahama A. Traoré (1 shared paper)Ying Zhan (1 shared paper)SeungBeum Suh (1 shared paper)
- Journals
- Nanomedicine Nanotechnology Biology and Medicine (1 paper)Anticancer Research (1 paper)Langmuir (1 paper)International Journal of Clinical Oncology (1 paper)Advanced Science (1 paper)
- Partner nations
- United StatesJapanSouth Korea
In The Last Decade
Ami Jo
9 papers receiving 366 citations
Peers
Comparison fields: 5 of 78
- Biotechnology 99
- Biomaterials 109
- Biomedical Engineering 189
- Pharmaceutical Science 22
- Condensed Matter Physics 24
Countries citing papers authored by Ami Jo
This map shows the geographic impact of Ami Jo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ami Jo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ami Jo more than expected).
Fields of papers citing papers by Ami Jo
This network shows the impact of papers produced by Ami Jo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ami Jo. The network helps show where Ami Jo may publish in the future.
Co-authors
The 25 scholars most cited alongside Ami Jo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 158 | |
| 2 | 2017 | 108 | |
| 3 | 2020 | 67 | |
| 4 | 2016 | 13 | |
| 5 | 2017 | 10 | |
| 6 | 2024 | 8 | |
| 7 | 2018 | 6 | |
| 8 | 2025 | 1 | |
| 9 | 2018 | 1 | |
| 10 | 2025 | 0 |
About Ami Jo
Ami Jo is a scholar working on Biomaterials, Biomedical Engineering, Molecular Biology, Oncology and Reproductive Medicine, having authored 10 papers that have together received 372 indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (4 papers), PARP inhibition in cancer therapy (2 papers), Graphene and Nanomaterials Applications (2 papers), Ovarian cancer diagnosis and treatment (2 papers), Endometrial and Cervical Cancer Treatments (1 paper), CRISPR and Genetic Engineering (1 paper), Inhalation and Respiratory Drug Delivery (1 paper) and Lymphoma Diagnosis and Treatment (1 paper). The work is most often cited by research in Biotechnology (99 citations), Biomaterials (109 citations), Biomedical Engineering (189 citations), Pharmaceutical Science (22 citations) and Condensed Matter Physics (24 citations). Ami Jo has collaborated with scholars based in United States, Japan and South Korea. Frequent co-authors include Richey M. Davis, Irving C. Allen, Veronica M. Ringel‐Scaia, Sheryl Coutermarsh‐Ott, Bahareh Behkam, Mahama A. Traoré, Ying Zhan, SeungBeum Suh, Yongle Du and Marion Ehrich. Their work appears in journals such as Nanomedicine Nanotechnology Biology and Medicine, Anticancer Research, Langmuir, International Journal of Clinical Oncology and Advanced Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.